Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

ATMEKSI

METHOCARBAMOL

Standard Dose
750MG(5ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ATMEKSI is listed in Drugs@FDA under application 219843 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient METHOCARBAMOL Form and strength SUSPENSION;ORAL - 750MG(5ML) Sponsor ROSEMONT PHARMS Submission history Latest submission status date: 2025-07-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview ATMEKSI is listed in Drugs@FDA under application 219843 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient METHOCARBAMOL Form and strength SUSPENSION;ORAL - 750MG(5ML) Sponsor ROSEMONT PHARMS Submission history Latest submission status date: 2025-07-30 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.